Zhejiang Wecome Pharmaceutical Co (SZSE:300878) 3-Year EBITDA Growth Rate : -35.70% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Zhejiang Wecome Pharmaceutical Co 3-Year EBITDA Growth Rate?

Zhejiang Wecome Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.19.

During the past 12 months, Zhejiang Wecome Pharmaceutical Co's average EBITDA Per Share Growth Rate was -166.40% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -35.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -19.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Zhejiang Wecome Pharmaceutical Co was 22.70% per year. The lowest was -35.70% per year. And the median was 1.40% per year.

Competitive Comparison of Zhejiang Wecome Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Zhejiang Wecome Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhejiang Wecome Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhejiang Wecome Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Zhejiang Wecome Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.

Zhejiang Wecome Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Zhejiang Wecome Pharmaceutical Co (SZSE:300878) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Zhejiang Wecome Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Zhejiang Wecome Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Wecome Pharmaceutical Co (SZSE:300878) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhejiang Wecome Pharmaceutical Co Ltd (SZSE:300878) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 2, Suisong Road, Lishui Economic Development Zone, Zhejiang Province, Lishui, CHN, 323000

Website

http://www.zjwk.com

Zhejiang Wecome Pharmaceutical Co Ltd is engaged in production and sales of modern Chinese medicine and western medicine. The company produces hard capsules, tablets, granules, soft capsules, pills (dropping pills).

Zhejiang Wecome Pharmaceutical Co (SZSE:300878) Headlines

No Headlines